inmazeb

Generic: atoltivimab, maftivimab, and odesivimab-ebgn

Labeler: regeneron pharmaceuticals, inc.
NDC Directory HUMAN PRESCRIPTION DRUG BLA Inactive Finished

Drug Facts

Product Profile

Brand Name inmazeb
Generic Name atoltivimab, maftivimab, and odesivimab-ebgn
Labeler regeneron pharmaceuticals, inc.
Dosage Form INJECTION, SOLUTION
Routes
INTRAVENOUS
Active Ingredients

atoltivimab 483.3 mg/14.5mL, maftivimab 483.3 mg/14.5mL, odesivimab 483.3 mg/14.5mL

Manufacturer
Regeneron Pharmaceuticals, Inc.

Identifiers & Regulatory

Product NDC 61755-019
Product ID 61755-019_03d5650a-82d9-4af5-9515-ea52c93733ef
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category BLA
Application Number BLA761169
Listing Expiration 2026-12-31
Marketing Start 2021-07-29

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 61755019
Hyphenated Format 61755-019

Supplemental Identifiers

RxCUI
2461536 2461539 2571682 2571685
UNII
UY9LQ8P6HW FJZ07Q63VY KOP95331M4

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name inmazeb (source: ndc)
Generic Name atoltivimab, maftivimab, and odesivimab-ebgn (source: ndc)
Application Number BLA761169 (source: ndc)
Routes
INTRAVENOUS
source: ndc

Resolved Composition

Strengths
  • 483.3 mg/14.5mL
source: ndc
Packaging
  • 1 VIAL, SINGLE-DOSE in 1 CARTON (61755-019-01) / 14.5 mL in 1 VIAL, SINGLE-DOSE (61755-019-00)
source: ndc

Packages (1)

61755-019-01 1 VIAL, SINGLE-DOSE in 1 CARTON (61755-019-01) / 14.5 mL in 1 VIAL, SINGLE-DOSE (61755-019-00)

Ingredients (3)

atoltivimab (483.3 mg/14.5mL) maftivimab (483.3 mg/14.5mL) odesivimab (483.3 mg/14.5mL)

Linked Drug Pages (1)

Inmazeb ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["INTRAVENOUS"], "spl_id": "03d5650a-82d9-4af5-9515-ea52c93733ef", "openfda": {"unii": ["UY9LQ8P6HW", "FJZ07Q63VY", "KOP95331M4"], "rxcui": ["2461536", "2461539", "2571682", "2571685"], "spl_set_id": ["0536b6fe-6fe5-4fd6-8cc6-1b481945c1fa"], "manufacturer_name": ["Regeneron Pharmaceuticals, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 VIAL, SINGLE-DOSE in 1 CARTON (61755-019-01)  / 14.5 mL in 1 VIAL, SINGLE-DOSE (61755-019-00)", "package_ndc": "61755-019-01", "marketing_start_date": "20210729"}], "brand_name": "Inmazeb", "product_id": "61755-019_03d5650a-82d9-4af5-9515-ea52c93733ef", "dosage_form": "INJECTION, SOLUTION", "product_ndc": "61755-019", "generic_name": "atoltivimab, maftivimab, and odesivimab-ebgn", "labeler_name": "Regeneron Pharmaceuticals, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Inmazeb", "active_ingredients": [{"name": "ATOLTIVIMAB", "strength": "483.3 mg/14.5mL"}, {"name": "MAFTIVIMAB", "strength": "483.3 mg/14.5mL"}, {"name": "ODESIVIMAB", "strength": "483.3 mg/14.5mL"}], "application_number": "BLA761169", "marketing_category": "BLA", "marketing_start_date": "20210729", "listing_expiration_date": "20261231"}